Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 81 (3), 1162-1171
- https://doi.org/10.1016/j.athoracsur.2005.08.002
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)The American Journal of Cardiology, 2005
- OPCAB and the incidence of atrial fibrillation: ignoring the current best available evidenceEuropean Journal of Cardio-Thoracic Surgery, 2005
- Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trialsInternational Journal of Cardiology, 2005
- Meta-analysis comparing drug-eluting stents with bare metal stentsThe American Journal of Cardiology, 2005
- A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery diseaseBritish Journal of Clinical Pharmacology, 2005
- Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting StentsDrugs, 2005
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Coronary Restenosis After Sirolimus-Eluting Stent ImplantationCirculation, 2003
- A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomesJournal of the American College of Cardiology, 2003
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001